| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1613710-01-2 | ARN-3236 |
≥98% | | 询价 |
| 2 | 2138814-32-9 | GSK3004774 |
≥98% | | 询价 |
| 3 | 890842-28-1 | GSK 650394 |
≥98% | | 询价 |
| 4 | 2101305-84-2 | GSK-690 |
≥98% | | 询价 |
| 5 | 892664-04-9 | GSK-269984A |
≥98% | | 询价 |
| 6 | 1253186-56-9 | GSK-7975A |
≥98% | | 询价 |
| 7 | 2121989-91-9 | GSK2850163 |
≥98% | | 询价 |
| 8 | 1260530-25-3 | GSK 525768A |
≥98% | | 询价 |
| 9 | 1404456-53-6 | GSK 2830371 |
≥98% | | 询价 |
| 10 | 1539314-06-1 | GSK-2881078 |
≥98% | | 询价 |
| 11 | 1010411-21-8 | GSK369796 Dihydrochloride |
≥98% | | 询价 |
| 12 | 1415925-18-6 | GSK2795039 |
≥98% | | 询价 |
| 13 | 8025-81-8 | Spiramycin |
≥98% | | 询价 |
| 14 | 1221277-90-2 | GSK-2033 |
≥98% | | 询价 |
| 15 | 1401-69-0 | Tylosin |
≥98% | | 询价 |
| 16 | 1508256-20-9 | Nazartinib S-enantiomer(EGF816) |
≥98% | | 询价 |
| 17 | 1422253-38-0 | PRI-724 |
≥98% | | 询价 |
| 18 | | SGE516 |
≥98% | | 询价 |
| 19 | 1632051-40-1 | SAGE 217 |
≥98% | | 询价 |
| 20 | 1018675-35-8 | CVT-12012 |
≥98% | | 询价 |
| 21 | 623152-17-0 | BMS-582949 |
≥98% | | 询价 |
| 22 | 1197376-85-4 | Capmatinib 2HCl |
≥98% | | 询价 |
| 23 | 2097002-61-2 | Selitrectinib(BAY 2731954 LOXO-195) |
≥98% | | 询价 |
| 24 | 1223403-58-4 | Larotrectinib(LOXO-101 ARRY-470) |
≥98% | | 询价 |
| 25 | 125314-64-9 | Ro 31-8220 |
≥98% | | 询价 |
| 26 | 109511-58-2 | U0126 |
≥98% | | 询价 |
| 27 | 1194961-19-7 | PRT-060318 |
≥98% | | 询价 |
| 28 | | PRT-060318 3HCl |
≥98% | | 询价 |
| 29 | 1403-36-7 | Chetomin |
≥98% | | 询价 |
| 30 | 7554-65-6 | Fomepizole |
≥98% | | 询价 |
| 31 | 648903-57-5 | BAY-61-3606 dihydrochloride |
≥98% | | 询价 |
| 32 | 113104-25-9 | NSC228155 |
≥98% | | 询价 |
| 33 | 1446790-62-0 | RO9021 |
≥98% | | 询价 |
| 34 | 1346242-81-6 | JNJ-42756493(Erdafitinib) |
≥98% | | 询价 |
| 35 | 102586-30-1 | NSC-12 |
≥98% | | 询价 |
| 36 | 5428-80-8 | Vacquinol-1 2HCl |
≥98% | | 询价 |
| 37 | 1096708-71-2 | MLN2480(TAK-580) |
≥98% | | 询价 |
| 38 | 912806-16-7 | BMS-582949 HCl |
≥98% | | 询价 |
| 39 | 839707-37-8 | Pluripotin(SC1) |
≥98% | | 询价 |
| 40 | | GMI-1359 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 1421373-65-0 | Dosimertinib |
≥98% | | 询价 |
| 42 | 2377335-74-3 | Coerulignone |
≥98% | | 询价 |
| 43 | 864289-85-0 | C-021(CCR4 antagonist) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 96996-50-8 | Cyanosafracin B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 1380887-60-4 | MK-8825 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 535-26-2 | Aposcopolamine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | | 1-NBDG |
≥98% | | 询价 |
| 48 | 651734-12-2 | 3-Oxo Ziprasidone |
≥98% | | 询价 |
| 49 | 1260617-10-4 | Clavulanate Potassium-Impurity E |
≥98% | | 询价 |
| 50 | 606968-52-9 | FC-131 |
≥98% | | 询价 |
| 51 | 51596-11-3 | Milbemycin A34 |
≥98% | | 询价 |
| 52 | 51596-10-2 | Milbemycin A3 |
≥98% | | 询价 |
| 53 | 133155-89-2 | Trapoxin A |
≥98% | | 询价 |
| 54 | 459420-09-8 | I3MT-3 |
≥98% | | 询价 |
| 55 | 131983-72-7 | Triticonazole |
≥98% | | 询价 |
| 56 | 82398-34-3 | Oxaliplatin Impurity E |
≥98% | | 询价 |
| 57 | 104872-42-6 | DOTMA |
≥98% | | 询价 |
| 58 | 153259-65-5 | Cilomilast(SB207499 Ariflo) |
≥98% | | 询价 |
| 59 | 171599-83-0 | Sildenafil Citrate(UK-92480 citrate Revatio VIAGRA) |
≥98% | | 询价 |
| 60 | 162401-32-3 | Roflumilast(BY217 B 9302107 BYK-20869 Daxas Daliresp) |
≥98% | | 询价 |
m.cnreagent.com